Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis

Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis. Open-Label Safety and Efficacy Evaluation of Tafamidis Meglumine in Subjects With Transthyretin  Amyloidosis (ATTR Amyloidosis)

Category & Conditions:
Neurological Diseases and Conditions
Medicine:
VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B3461023
Open Plain Language Summary Result:Click here